We are live on
!
Find out more
IA
Investor AB Portfolio holdings
AUM
$14.4B
1-Year Est. Return
4.07%
This Fund
S&P 500
This Quarter
Est. Return
+0.77%
1 Year Est. Return
+4.07%
3 Year Est. Return
+86.64%
5 Year Est. Return
+58.64%
10 Year Est. Return
+329.22%
AUM
$15.1B
AUM Growth
+$9.45B
(+167%)
Cap. Flow
+$9.96B
Cap. Flow
% of AUM
65.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
4
Increased
2
Reduced
2
Closed
6
Avg Time Held
6.7
quarters
Top 10 Avg Time Held
6.1
quarters
Top 20 Avg Time Held
6.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$9.95B |
| 2 |
Nasdaq
NDAQ
|
+$17.9M |
| 3 |
Cellebrite
CLBT
|
+$829K |
| 4 |
Kyivstar Group
KYIV
|
+$703K |
| 5 |
Verizon
VZ
|
+$524K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$1.21M |
| 2 |
Check Point Software Technologies
CHKP
|
+$928K |
| 3 |
Coherent
COHR
|
+$687K |
| 4 |
Carnival Corporation Ltd
CCL
|
+$641K |
| 5 |
D-Wave Quantum Inc
QBTS
|
+$392K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 67.36% |
| 2 | Financials | 32.61% |
| 3 | Technology | 0.01% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
AstraZeneca
AZN
$246B
| $10.2B | 67.27% |
+51,587,810
| New | +$9.95B |
2026 Q1
0 quarters
|
|
|
2
Nasdaq
NDAQ
$52.8B
| $4.93B | 32.61% |
58,382,426
+200,000
| +0.3% | +$17.9M |
2013 Q2
51 quarters
|
|
3
MediWound
MDWD
$159M
| $14M | 0.09% |
872,093
| – | – |
2024 Q3
6 quarters
|
|
|
4
Cellebrite
CLBT
$2.85B
| $758K | 0.01% |
+55,000
| New | +$829K |
2026 Q1
0 quarters
|
|
|
5
Coherent
COHR
$58B
| $715K | ﹤0.01% |
3,000
-3,000
| -50% | -$687K |
2025 Q4
1 quarter
|
|
|
6
Kyivstar Group
KYIV
$2.78B
| $601K | ﹤0.01% |
+59,402
| New | +$703K |
2026 Q1
0 quarters
|
|
|
7
Verizon
VZ
$177B
| $567K | ﹤0.01% |
+11,300
| New | +$524K |
2026 Q1
0 quarters
|
|
8
Corsair Gaming
CRSR
$1.45B
| $553K | ﹤0.01% |
99,711
-25,000
| -20% | -$138K |
2025 Q4
1 quarter
|
|
9
Whirlpool
WHR
$1.86B
| $253K | ﹤0.01% |
4,700
+1,000
| +27% | +$73.4K |
2025 Q1
4 quarters
|
|
10
BioMarin Pharmaceuticals
BMRN
$10.8B
| $209K | ﹤0.01% |
3,700
| – | – |
2025 Q1
4 quarters
|
|
|
11
Carnival Corporation Ltd
CCL
$35.8B
| – | – |
-21,000
| Closed | -$641K | – |
|
|
12
Check Point Software Technologies
CHKP
$14B
| – | – |
-5,000
| Closed | -$928K | – |
|
|
13
Capital One
COF
$123B
| – | – |
-5,000
| Closed | -$1.21M | – |
|
|
14
D-Wave Quantum Inc
QBTS
$5.27B
| – | – |
-15,000
| Closed | -$392K | – |
|
15
SS&C Technologies
SSNC
$19B
| – | – |
-2,500
| Closed | -$219K | – |
|
Similar funds
ZIG
AB
AM
NYLIM
SMDAM
AAMU
BIP
CII
Investor AB's Q1 2026 Portfolio in Review
As of Q1 2026, Investor AB held 16 positions worth $15.1B, up 167% from $5.67B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Investor AB deployed $9.96B of net new capital in Q1 2026, opening 4 new positions and adding to 2 existing holdings. Its largest new stake was AstraZeneca: 51,587,810 shares worth $10.2B.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 0.29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Coherent, an estimated $687K trimmed.
- Investor AB's largest Q1 2026 buy was AstraZeneca: 51,587,810 shares worth $10.2B.
- Investor AB added most to Nasdaq in Q1 2026, an estimated $17.9M increase.
- Investor AB's biggest Q1 2026 reduction was Coherent, cutting an estimated $687K.
- Investor AB fully exited Capital One in Q1 2026, selling an estimated $1.21M.
- Investor AB's ten largest holdings make up 100% of its $15.1B portfolio in Q1 2026.
- Investor AB opened 4 new positions and closed 6 in Q1 2026.
- Investor AB's portfolio value rose 167% quarter-over-quarter to $15.1B.
Based on Investor AB's 13F filing for Q1 2026, filed 15 May 2026.